Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery
- Conditions
- Epiretinal MembraneCataract Senile
- Interventions
- Procedure: Phacoemulsification, intraocular lens implant, vitrectomy.
- Registration Number
- NCT03045367
- Lead Sponsor
- Clinica Oculistica dell'Università di Torino
- Brief Summary
This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- age > 55 years
- visual acuity ≤ 20/40
- idiopathic epiretinal membrane
- cataract
- Amsler test positive for metamorphopsia.
- previous ocular interventions
- other ocular diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Outpatients Phacoemulsification, intraocular lens implant, vitrectomy. Phacoemulsification, intraocular lens implant, vitrectomy.
- Primary Outcome Measures
Name Time Method Metamorphopsia Change in metamorphopsia from baseline at 180 days. Change in spatial degree of distortion perception
Area of central scotoma Change in area of central scotoma from baseline at 180 days Change in area, in square pixel, of central scotoma
Visual Acuity Change in visual acuity from baseline at 180 days Change in LogMAR visual acuity
Central fovea thickness Change in fovea thickness from baseline at 180 days Change in fovea thickness in µm at the Sd OCT
- Secondary Outcome Measures
Name Time Method